Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
Pharmaceuticals December 31, 2022 Antonio Munafò, Davide Arillotta, Guido Mannaioni et al. 15 citations
Psilocybin has been suggested as a promising transdiagnostic treatment strategy for a wide range of psychiatric disorders. Recent findings showed that psychedelic-assisted/”psycholitic” psychotherapy should provide significant and sustained alleviation of depressive symptoms. However, to date, there have been several study limitations (e.g., small sample sizes, blinding, limited follow-up,...